<DOC>
	<DOCNO>NCT00071084</DOCNO>
	<brief_summary>The purpose trial determine effect HuMax-CD4 , treatment advanced stage ( late stage ) cutaneous T-cell lymphoma ( CTCL ) . Almost patient affected late stage CTCL many cancerous cell bear receptor call CD4 . HuMax-CD4 investigational drug direct receptor . There placebo trial ; patient treat HuMax-CD4 . The response rate , duration response , relief symptom , safety profile HuMax-CD4 evaluate trial .</brief_summary>
	<brief_title>Clinical Trial HuMax-CD4 , New Drug Treat Advanced Stage T-Cell Lymphoma Skin .</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Cutaneous</mesh_term>
	<criteria>Inclusion criterion Medical diagnosis CTCL , positivity CD4 receptor . Late stage CTCL . Have receive least one prior anticancer therapy inadequate effect . WHO performance status 0,1 2 Male female , age 18 older . Signed informed consent . Exclusion Criteria Certain rare type CTCL . Previous treatment antiCD4 medication . More two previous treatment systemic chemotherapy . Certain antipsoriasis anticancer therapy within last 4 week enter trial . Some type steroid treatment less two week enter trial . Prolonged exposure sunlight UV light trial . Other cancer disease , except certain skin cancer cervix cancer . Chronic infectious disease require medication . Certain serious medical condition , include kidney liver disease , psychiatric illness , stomach , lung , heart , hormonal , nerve blood disease . Certain laboratory value high low . HIV positivity . Pregnant breastfeed woman . Women childbearing age unable unwilling use IUD hormonal birth control whole trial . If participate another trial different new drug 4 week enter trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Skin cancer</keyword>
	<keyword>Lymphoma</keyword>
	<keyword>Mycosis fungoides</keyword>
	<keyword>Sezary syndrome</keyword>
</DOC>